» Articles » PMID: 34924390

Utility of Machine Learning Approach with Neuropsychological Tests in Predicting Functional Impairment of Alzheimer's Disease

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2021 Dec 20
PMID 34924390
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In assessing the levels of clinical impairment in dementia, a summary index of neuropsychological batteries has been widely used in describing the overall functional status.

Objective: It remains unexamined how complex patterns of the test performances can be utilized to have specific predictive meaning when the machine learning approach is applied.

Methods: In this study, the neuropsychological battery (CERAD-K) and assessment of functioning level (Clinical Dementia Rating scale and Instrumental Activities of Daily Living) were administered to 2,642 older adults with no impairment (n = 285), mild cognitive impairment (n = 1,057), and Alzheimer's disease (n = 1,300). Predictive accuracy on functional impairment level with the linear models of the single total score or multiple subtest scores (Model 1, 2) and support vector regression with low or high complexity (Model 3, 4) were compared across different sample sizes.

Results: The linear models (Model 1, 2) showed superior performance with relatively smaller sample size, while nonlinear models with low and high complexity (Model 3, 4) showed an improved accuracy with a larger dataset. Unlike linear models, the nonlinear models showed a gradual increase in the predictive accuracy with a larger sample size (n > 500), especially when the model training is allowed to exploit complex patterns of the dataset.

Conclusion: Our finding suggests that nonlinear models can predict levels of functional impairment with a sufficient dataset. The summary index of the neuropsychological battery can be augmented for specific purposes, especially in estimating the functional status of dementia.

Citing Articles

Understanding machine learning applications in dementia research and clinical practice: a review for biomedical scientists and clinicians.

Wang Y, Liu S, Spiteri A, Huynh A, Chu C, Masters C Alzheimers Res Ther. 2024; 16(1):175.

PMID: 39085973 PMC: 11293066. DOI: 10.1186/s13195-024-01540-6.


Executive Summary of 2023 International Conference of the Korean Dementia Association (IC-KDA 2023): A Report From the Academic Committee of the Korean Dementia Association.

Kim G, Kim J, Choi W, Kim Y, Lee K, Jang J Dement Neurocogn Disord. 2024; 23(2):75-88.

PMID: 38720824 PMC: 11073927. DOI: 10.12779/dnd.2024.23.2.75.


Applications of Artificial Intelligence in the Neuropsychological Assessment of Dementia: A Systematic Review.

Veneziani I, Marra A, Formica C, Grimaldi A, Marino S, Quartarone A J Pers Med. 2024; 14(1).

PMID: 38276235 PMC: 10820741. DOI: 10.3390/jpm14010113.


Investigating predictors of progression from mild cognitive impairment to Alzheimer's disease based on different time intervals.

Wu Y, Wang X, Gu C, Zhu J, Fang Y Age Ageing. 2023; 52(9).

PMID: 37740920 PMC: 10518045. DOI: 10.1093/ageing/afad182.

References
1.
Bilder R, Reise S . Neuropsychological tests of the future: How do we get there from here?. Clin Neuropsychol. 2018; 33(2):220-245. PMC: 6422683. DOI: 10.1080/13854046.2018.1521993. View

2.
Chandler M, Lacritz L, Hynan L, Barnard H, Allen G, Deschner M . A total score for the CERAD neuropsychological battery. Neurology. 2005; 65(1):102-6. DOI: 10.1212/01.wnl.0000167607.63000.38. View

3.
Matteau E, Dupre N, Langlois M, Jean L, Thivierge S, Provencher P . Mattis Dementia Rating Scale 2: screening for MCI and dementia. Am J Alzheimers Dis Other Demen. 2011; 26(5):389-98. PMC: 10845364. DOI: 10.1177/1533317511412046. View

4.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939-44. DOI: 10.1212/wnl.34.7.939. View

5.
Battista P, Salvatore C, Berlingeri M, Cerasa A, Castiglioni I . Artificial intelligence and neuropsychological measures: The case of Alzheimer's disease. Neurosci Biobehav Rev. 2020; 114:211-228. DOI: 10.1016/j.neubiorev.2020.04.026. View